Co-Authors
This is a "connection" page, showing publications co-authored by Cataldo Patruno and Luca Stingeni.
Connection Strength
1.698
-
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
Score: 0.241
-
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
Score: 0.238
-
Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis. 2021 09; 9(3):622-623.
Score: 0.238
-
Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117.
Score: 0.234
-
The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis. 2020 08; 83(2):174-175.
Score: 0.221
-
Dupilumab and COVID-19: What should we expect? Dermatol Ther. 2020 Jul; 33(4):e13502.
Score: 0.221
-
Italian Guidelines in Patch Testing - adapted from the European Society of Contact Dermatitis (ESCD). G Ital Dermatol Venereol. 2019 Jun; 154(3):227-253.
Score: 0.202
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
Score: 0.058
-
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease. Arch Dermatol Res. 2017 Aug; 309(6):443-452.
Score: 0.045